Our findings revealed that suppression of SIRT6 activity was sufficient to increase Utrn expression to a level that improved skeletal muscles function in dystrophic mdx muscles, suggesting that manipulation of gene expression at the epigenetic level is a realistic option for the treatment of DMD. This evidence concerns the gene SIRT6 and Duchenne muscular dystrophy.